Customizing anticoagulation strategies during leukapheresis to limit citrate exposure-Reference-Cited by-同舟云学术

Customizing anticoagulation strategies during leukapheresis to limit citrate exposure

Published:2016-12-15 Issue:2 Volume:12 Page:297-306
ISSN:1751-2816
Container-title:ISBT Science Series
language:en
Short-container-title:VOXS

Author:

McMannes J. L.¹,Hershberger J.¹,Parker D. M.²,De Reys S.³,Loos T.³,Hematti P.⁴⁵

Affiliation:

1. Blood and Bone Marrow Transplant Program; University of Wisconsin Hospital and Clinics; Madison WI USA

2. Innovation and Development; Terumo BCT; Lakewood CO USA

3. Scientific Services and Support; Terumo BCT; Lakewood CO USA

4. Division of Hematology/Oncology; University of Wisconsin-Madison School of Medicine and Public Health; Madison WI USA

5. University of Wisconsin Carbone Cancer Center; Madison WI USA

Publisher

Wiley

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/voxs.12337/fullpdf

Reference17 articles.

1. Anticoagulation techniques in apheresis: from heparin to citrate and beyond;Lee;J Clin Apher,2012

2. Evidence that calcium regulates platelet function;Detwiler;Thromb Haemost,1978

3. Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection;Agarwal;Blood Transfus,2012

4. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation;Bolan;Transfusion,2002

5. Management of anticoagulation-associated toxicity during large-volume leukapheresis of peripheral blood stem cell donors;Bolan;Blood,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous Stem Cell Transplantation for Autoimmune Diseases;Comprehensive Hematology and Stem Cell Research;2024